Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-006520
Filing Date
2023-04-13
Accepted
2023-04-13 16:52:39
Documents
2
Period of Report
2023-04-11

Document Format Files

Seq Description Document Type Size
1 form3-04132023_080428.html 3  
1 form3-04132023_080428.xml 3 1635
2 ex24-04132023_080437.htm EX-24 9747
  Complete submission text file 0001415889-23-006520.txt   12714
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Issuer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O OMEGA THERAPEUTICS, INC. 20 ACORN PARK D CAMBRIDGE MA 02140
Business Address
Levy Elliott M. (Reporting) CIK: 0001858745 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37687 | Film No.: 23818955